Literature DB >> 15118503

Age-related macular degeneration and depression: a review of recent research.

Robin J Casten1, Barry W Rovner, William Tasman.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to summarize current research findings regarding relationships between depression and age-related macular degeneration (AMD). RECENT
FINDINGS: The current literature indicates that the prevalence of depression among patients with AMD is fairly high (approximately 30%) and that depression is a major cause of disability among patients with AMD, even when severity of vision loss is considered. Interventions to alleviate the emotional distress associated with vision loss are also discussed.
SUMMARY: Several studies indicate that AMD is a risk factor for depression, and this has serious consequences for the quality of life among patients with AMD.

Entities:  

Mesh:

Year:  2004        PMID: 15118503     DOI: 10.1097/01.icu.0000120710.35941.3f

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  45 in total

1.  Why visually impaired older adults often do not receive mental health services: the patient's perspective.

Authors:  Hilde P A van der Aa; Mirke Hoeben; Linda Rainey; Ger H M B van Rens; Hilde L Vreeken; Ruth M A van Nispen
Journal:  Qual Life Res       Date:  2014-11-15       Impact factor: 4.147

2.  Sensory impairments and their associations with functional disability in a sample of the oldest-old.

Authors:  Verena R Cimarolli; Daniela S Jopp
Journal:  Qual Life Res       Date:  2014-03-29       Impact factor: 4.147

3.  Recent advances in the treatment of age-related macular degeneration.

Authors:  Ameenat Lola Solebo; Romesh I Angunawela; Samipa Dasgupta; John Marshall
Journal:  Br J Gen Pract       Date:  2008-05       Impact factor: 5.386

4.  Cranial Nerve II: Vision.

Authors:  Paulette Marie Gillig; Richard D Sanders
Journal:  Psychiatry (Edgmont)       Date:  2009-09

5.  Behavioral activation for depression in older adults: theoretical and practical considerations.

Authors:  Courtney Allyn Polenick; Stephen Ray Flora
Journal:  Behav Anal       Date:  2013

6.  The macular degeneration and aging study: Design and research protocol of a randomized trial for a psychosocial intervention with macular degeneration patients.

Authors:  Silvia Sörensen; Katherine White; Wingyun Mak; Katherine Zanibbi; Wan Tang; Amanda O'Hearn; Mark T Hegel
Journal:  Contemp Clin Trials       Date:  2015-03-24       Impact factor: 2.226

7.  [The influence of visual rehabilitation on secondary depressive disorders due to age-related macular degeneration. A randomized controlled pilot study].

Authors:  A Mielke; K Wirkus; R Niebler; G Eschweiler; N X Nguyen; S Trauzettel-Klosinski
Journal:  Ophthalmologe       Date:  2013-05       Impact factor: 1.059

8.  Rehabilitation Referral for Patients With Irreversible Vision Impairment Seen in a Public Safety-Net Eye Clinic.

Authors:  M Austin Coker; Carrie E Huisingh; Gerald McGwin; Russell W Read; Mark W Swanson; Laura E Dreer; Dawn K DeCarlo; Lindsay Gregg; Cynthia Owsley
Journal:  JAMA Ophthalmol       Date:  2018-04-01       Impact factor: 7.389

Review 9.  Update on depression and age-related macular degeneration.

Authors:  Robin J Casten; Barry W Rovner
Journal:  Curr Opin Ophthalmol       Date:  2013-05       Impact factor: 3.761

10.  Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).

Authors:  Matthias Lüke; Focke Ziemssen; Michael Völker; Elke Altpeter; Julia Beutel; Dorothea Besch; Karl Ulrich Bartz-Schmidt; Faik Gelisken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.